Shindel Alan W, Bullock Travis L, Brandes Steven
Washington University in Saint Louis-Department of Surgery, Division of Urology, St. Louis, MO, USA.
Washington University in Saint Louis-Department of Surgery, Division of Urology, St. Louis, MO, USA.
J Sex Med. 2008 Apr;5(4):954-964. doi: 10.1111/j.1743-6109.2007.00674.x. Epub 2007 Nov 27.
Peyronie's disease (PD) is a poorly understood clinical entity. Aim. We endeavored to determine how contemporary urologists in the United States manage PD.
A randomly generated mailing list of 996 practicing urologists was generated from the American Urologic Association member directory. A specifically designed survey was mailed with a cover letter and a postage-paid return envelope.
Our survey assessed several practice-related factors and asked questions of how the subject would manage various presentations of PD in their practice. Four cases were presented: case 1, a healthy 55-year-old man with painless 30 degrees dorsal curvature of 16 months duration; case 2, a 60-year-old man with 35 degrees dorsal curvature, 4/10 pain on visual analog scale, of 6 months duration; case 3, a 62-year-old man with painless 60 degrees dorsal curvature and erectile dysfunction responsive to alprostadil suppository of 2 years duration; and case 4, a 50-year-old man with mid-shaft waist deformity, foreshortening, no pain/curvature/erectile dysfunction.
Responses were received from 236 (24%) practicing urologists. Vitamin E was the preferred initial management for 70% of respondents, with observation, Potaba (Glenwood, Englewood, New Jersey, USA), colchicine, verapamil injections, and verapamil gel favored by 32, 20, 12, 7, and 10% of respondents, respectively. Fifty-seven percent of respondents performed surgery for PD, with penile prostheses, Nesbit procedure, grafting, and plication used by 76, 66, 55, and 51% of respondents, respectively. Medical therapy and/or observation was the preferred management for all of the cases except case 3, for which penile prosthesis placement and referral were the favored options by 39 and 30% of urologists, respectively.
Medical therapy is the initial treatment for PD among American urologists. Penile prosthesis is the treatment of choice in impotent patients. Most American urologists conform to recommended practice patterns in the management of PD.
佩罗尼氏病(PD)是一种了解甚少的临床病症。目的:我们试图确定美国当代泌尿外科医生如何治疗佩罗尼氏病。
从美国泌尿外科协会会员名录中随机生成一份包含996名执业泌尿外科医生的邮寄名单。随一封附信和一个邮资已付的回邮信封寄出一份专门设计的调查问卷。
我们的调查评估了几个与临床实践相关的因素,并询问受访者在其临床实践中会如何处理佩罗尼氏病的各种表现形式。给出了四个病例:病例1,一名55岁健康男性,有持续16个月的无痛性30度背侧弯曲;病例2,一名60岁男性,有35度背侧弯曲,视觉模拟评分法疼痛评分为4/10,病程6个月;病例3,一名62岁男性,有无痛性60度背侧弯曲及对前列地尔栓剂有反应的勃起功能障碍,病程2年;病例4,一名50岁男性,阴茎中段腰部畸形、缩短,无疼痛/弯曲/勃起功能障碍。
收到了236名(24%)执业泌尿外科医生的回复。70%的受访者首选维生素E进行初始治疗,分别有32%、20%、12%、7%和10%的受访者倾向于观察、服用Potaba(美国新泽西州恩格尔伍德的格伦伍德公司生产)、秋水仙碱、维拉帕米注射剂和维拉帕米凝胶。57%的受访者会对佩罗尼氏病进行手术治疗,分别有76%、66%‘55%和51%的受访者使用阴茎假体、内斯比特手术、移植和折叠术等方法。除病例3外,药物治疗和/或观察是所有病例的首选治疗方法,对于病例3,分别有39%和30%的泌尿外科医生倾向于阴茎假体植入和转诊。
在美国泌尿外科医生中,药物治疗是佩罗尼氏病的初始治疗方法。阴茎假体是阳痿患者的首选治疗方法。大多数美国泌尿外科医生在佩罗尼氏病的治疗中遵循推荐的治疗模式。